Backward Running on a Negative Slope as a Treatment for Achilles Tendinopathy in Runners

November 16, 2020 updated by: Meuhedet. Healthcare Organization

This study will look to evaluate the feasibility of a backwards downhill running program as an option for the treatment of Achilles tendinopathy in runners. It is known that exercise on the Achilles tendon during elongation (eccentric exercise) improves tendon function after injury. However, during recovery, the patient is required to stop tendon-loading activities such as jumps and sprints. Therefore, during recovery, athletes decline in physical fitness.

Backward running on a negative slope can achieve a biomechanical load similar to eccentric exercise without decreasing physical fitness.

Study Overview

Detailed Description

The study was a prospective, single-arm feasibility study. Participants were patients who met the entry criteria and were referred to the Meuhedet health service Physical Therapy outpatient clinic, Jerusalem, from September 2019 to February 2020. The sample size was based on previous recommendations for pilot and feasibility studies (Julious 2005; Billingham, Whitehead, and Julious 2013). Inclusion criteria were: AT that was clinically determined by an orthopedic surgeon (E.S) according to nontraumatic pain and tenderness at the Achilles tendon and report of decreased activity levels secondary to Achilles pain; a history of running for at least one session a week in the past three months; age > 18 and < 70. Exclusion criteria were having other lower extremity injuries; prior treatment with eccentric exercise or currently receiving Physical Therapy for AT; received a steroid injection into the tendon in the three months prior, or underwent Achilles tendon surgery.

Participants received a total of nine treatment sessions, twice a week for a total of five weeks. Each treatment consisted of backward walking / running over an 8º negatively inclined treadmill. (Landice L7 Rehabilitation treadmill, New Jersey, USA) with a warmup and a cooldown on a stationary bike. A detailed description of the protocol is presented in Table 1. As backward locomotion on a treadmill was novel for all participants they were advised to hold the treadmill handles during the adjustment period (treatment sessions 1-3). Participants were also instructed to refrain from specific sports which involve continuous jumping and forward running throughout the intervention period. Patients were informed that if they do not feel comfortable with the training protocol, they could terminate their participation at any point.

Assessments took place at baseline, pretreatment four, pretreatment six, and at a separate meeting after treatment nine

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jerusalem, Israel
        • Meuhedet Health Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Distinct tenderness of Achilles tendon with no pain in the neighboring structures.
  2. Nontraumatic diffuse pain in the posterior calf with local tenderness in the Achilles tendon.
  3. A history of running for at least one session a week in the past three months.
  4. Age > 18 and < 70

Exclusion Criteria:

  1. Achilles pain longer than six months.
  2. Patients with an additional lower extremity injury unable to bear full weight on the limb.
  3. Patients who are currently receiving physical therapy for Achilles tendinopathy, have received a steroid injection into the tendon in the three months prior, or underwent Achilles tendon surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Backward runners
Training protocol patients
Running backward on a treadmill with a negative slope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VISA-A questionnaire
Time Frame: baseline
Subjective questionnaire specific for Achilles tendinopathy
baseline
VISA-A questionnaire
Time Frame: two weeks
Subjective questionnaire specific for Achilles tendinopathy
two weeks
VISA-A questionnaire
Time Frame: three weeks
Subjective questionnaire specific for Achilles tendinopathy
three weeks
VISA-A questionnaire
Time Frame: five weeks
Subjective questionnaire specific for Achilles tendinopathy
five weeks
Number of single legged heel raises from a flat surface before the onset of pain
Time Frame: baseline
Heel raise height will be defined by a pretest of one maximum single legged heel raise assessed by a measuring tape in centimeters
baseline
Number of single legged heel raises from a flat surface before the onset of pain
Time Frame: two weeks
Heel raise height will be defined by a pretest of one maximum single legged heel raise assessed by a measuring tape in centimeters
two weeks
Number of single legged heel raises from a flat surface before the onset of pain
Time Frame: three weeks
Heel raise height will be defined by a pretest of one maximum single legged heel raise assessed by a measuring tape in centimeters
three weeks
Number of single legged heel raises from a flat surface before the onset of pain
Time Frame: five weeks
Heel raise height will be defined by a pretest of one maximum single legged heel raise assessed by a measuring tape in centimeters
five weeks
Onset of relevant Achilles tendon pain (measured in seconds) during Forward running at a self-selected comfortable pace on a treadmill
Time Frame: baseline
Forward running on treadmill until the onset of relevant pain
baseline
Onset of relevant Achilles tendon pain (measured in seconds) during Forward running at a self-selected comfortable pace on a treadmill
Time Frame: three weeks
Forward running on treadmill until the onset of relevant pain
three weeks
Onset of relevant Achilles tendon pain (measured in seconds) during Forward running at a self-selected comfortable pace on a treadmill
Time Frame: five weeks
Forward running on treadmill until the onset of relevant pain
five weeks
Compliance
Time Frame: five weeks
Treatment sessions will be calculated upon the patient's completion of the full treatment protocol for that specific session. Inclusion will be terminated upon lack of fulfilling the treatment protocol or failing to complete a total of at least eight sessions.
five weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Shmuel Springer, prof, Ariel University, Physical Therapy Department

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2019

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

November 9, 2020

First Submitted That Met QC Criteria

November 16, 2020

First Posted (Actual)

November 17, 2020

Study Record Updates

Last Update Posted (Actual)

November 17, 2020

Last Update Submitted That Met QC Criteria

November 16, 2020

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendinopathy

Clinical Trials on Backwards running on a Treadmil with a negative slope

Subscribe